Platform Features
Platform Features
Features
Investment Products
Private Wealth Management
Trading Tools
Market Data Services
Analysis Tools
News Services
For Developers
Account Types
For Individuals
For Institutions
Café
More
Log in / Sign up
© 2026 Longbridge｜
Terms of Service
Privacy Policy
Disclaimer
IMMUNEONCO-B
01541
4.080
10.27% ( +0.380 )
Delay Closed: Aug 27, 16:08:29
Start trading
Overview
Overview
News
News
Posts
Posts
Financials
Financials
Forecast
Forecast
Valuation
Valuation
Shareholders
Shareholders
Profile
Profile
All Shareholders
Institutional Holders
Insiders
All Shareholders
Shareholder Type
Public and others
63.13%
Individuals & Insiders
16.33%
ESOPs
10.59%
VC/PE firms
8.43%
Institutions
1.52%
Major Shareholders
Latest
Major Shareholders Latest
Shareholder
% Held
Shares Held
Change %
Shares Changed
Report Date
Wenzhi Tian
Founder, CEO, Chief Scientific Officer & Chairman of the Board
16.33%
70.48M
0.01%
+50.00K
05/19/2026
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. , ESOP
10.59%
45.70M
0.00%
+0
05/19/2026
Shanghai Yongkan Investment Management Co., Ltd.
8.43%
36.39M
0.00%
+0
12/31/2025
GF Fund Management Co., Ltd.
0.76%
3.28M
0.00%
+0
06/30/2025
E Fund Management Co., Ltd.
0.41%
1.78M
0.00%
+0
06/30/2025
State Street Investment Management
0.23%
977.60K
<0.01%
+38.40K
07/31/2026
Zhong Ou Fund Management Co., Ltd
0.09%
399.00K
0.00%
+0
06/30/2025
Fullgoal Fund Management Co. Ltd.
0.02%
88.60K
0.00%
+0
12/31/2025
Dimensional Fund Advisors LP
<0.01%
18.80K
<0.01%
+2.07K
04/30/2026
